Rheumatologische Schwerpunktpraxis

At Rheumatologische Schwerpunktpraxis im Ärztehaus am Walter-Schreiber-Platz in Berlin, clinical research in immune system diseases focuses on conditions such as psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, and giant cell arteritis. The trials mainly aim to test new therapies, assess symptom control, and monitor long-term safety in people living with chronic inflammatory disease.

• Studies in psoriatic arthritis and related inflammatory joint disease
• Research on rheumatoid arthritis treatment effectiveness and safety
• Trials in axial spondyloarthritis and flare prevention
• Evaluation of therapies for giant cell arteritis

This area includes both short-term symptom improvement and longer-term follow-up, with an emphasis on how well treatments work in everyday patients.

The site conducts a strong portfolio of studies in musculoskeletal diseases, especially rheumatoid arthritis, psoriatic arthritis, and radiographic as well as non-radiographic axial spondyloarthritis. These trials are designed to evaluate whether new treatments can reduce pain, stiffness, and inflammation while improving daily function.

• Clinical research in rheumatoid arthritis across different levels of disease activity
• Studies for axial spondyloarthritis, including ankylosing spondylitis
• Trials measuring improvement in joint symptoms and physical well-being
• Assessment of treatment response and durability over time

The research reflects a practical focus on therapies that may help patients manage chronic joint disease more effectively.

Research in skin and connective tissue diseases at this rheumatology specialty practice includes inflammatory conditions with both joint and skin involvement, particularly psoriatic arthritis. The main purpose of these trials is to test new treatment options, compare them with existing therapies, and understand how safely they can be used over time.

• Focused studies in psoriatic arthritis and active disease control
• Comparisons of emerging therapies against established treatment options
• Long-term safety and tolerability research
• Evaluation of improvements in joint and skin-related symptoms

This research area is especially relevant for patients whose inflammatory disease affects both movement and skin health.

A further theme at the Rheumatologische Schwerpunktpraxis is the study of immune system processes involved in chronic inflammation. These trials are aimed at understanding how targeted therapies influence the immune response, with the goal of improving disease control in conditions such as rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis.

• Investigations of immune-targeted treatment approaches
• Research into reducing inflammation and preventing disease flares
• Studies of treatment response in chronic autoimmune conditions
• Ongoing evaluation of safety alongside clinical benefit

The work here helps clarify how newer therapies may better regulate inflammation in patients with long-standing immune-mediated disease.